Legal & General Group
AVIR icon

Legal & General Group’s Atea Pharmaceuticals AVIR Stock Holding History

Legal & General Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9K Buy
7,082
+1,149
+19% +$5.71K ﹤0.01% 2919
2026
Q1 		$31.9K Hold
5,933
– – ﹤0.01% 2813
2025
Q4 		$21.2K Sell
5,933
-1,283
-18% -$4.08K ﹤0.01% 3003
2025
Q3 		$20.9K Hold
7,216
– – ﹤0.01% 3014
2025
Q2 		$26K Hold
7,216
– – ﹤0.01% 2898
2025
Q1 		$21.6K Hold
7,216
– – ﹤0.01% 2917
2024
Q4 		$24.2K Hold
7,216
– – ﹤0.01% 2961
2024
Q3 		$24.2K Buy
7,216
+1,172
+19% +$4.25K ﹤0.01% 2974
2024
Q2 		$20K Hold
6,044
– – ﹤0.01% 3016
2024
Q1 		$24.4K Hold
6,044
– – ﹤0.01% 2891
2023
Q4 		$18.4K Hold
6,044
– – ﹤0.01% 3066
2023
Q3 		$18.1K Sell
6,044
-1,071
-15% -$3.64K ﹤0.01% 3075
2023
Q2 		$26.6K Sell
7,115
-6,256
-47% -$23.4K ﹤0.01% 2989
2023
Q1 		$44.8K Sell
13,371
-15,880
-54% -$64.4K ﹤0.01% 2896
2022
Q4 		$141K Hold
29,251
– – ﹤0.01% 2725
2022
Q3 		$167K Buy
29,251
+744
+3% +$5.7K ﹤0.01% 2683
2022
Q2 		$203K Buy
28,507
+16,110
+130% +$110K ﹤0.01% 2623
2022
Q1 		$90K Hold
12,397
– – ﹤0.01% 2891
2021
Q4 		$111K Hold
12,397
– – ﹤0.01% 2888
2021
Q3 		$435K Buy
12,397
+4,317
+53% +$120K ﹤0.01% 2453
2021
Q2 		$174K Buy
8,080
+6,571
+435% +$197K ﹤0.01% 2571
2021
Q1 		$93K Sell
1,509
-31,821
-95% -$2.15M ﹤0.01% 2643
2020
Q4 		$1.39M Buy
+33,330
New +$1.07M ﹤0.01% 2019

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Legal & General Group's AVIR Position: Q2 2026 in Review

Legal & General Group increased its Atea Pharmaceuticals (AVIR) stake by 19% in Q2 2026, buying an estimated $5.71K and bringing the position to 7,082 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

Legal & General Group first reported a position in AVIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.39M in Q4 2020. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Legal & General Group held 7,082 shares of Atea Pharmaceuticals worth $32.9K as of Q2 2026.
  • Legal & General Group bought 1,149 Atea Pharmaceuticals shares in Q2 2026, an estimated $5.71K.
  • Atea Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2919 holding.
  • Legal & General Group first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Legal & General Group's Atea Pharmaceuticals position peaked at $1.39M in Q4 2020.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.